That the work is original, and due credit is given to others where appropriate Acceptance and acknowledgement that assignments found to be plagiarized in any way will be subject to sanctions under the Universitys Code of Behavior on Academic Matters. Please pay attention to the course outline for specific formatting requirements set by instructors. Assignments are to be submitted using student ID numbers only; do not include your name. Please note that assignments that include names or that do not have the box below checked will not be graded.
Please check the box and record your student
number below to indicate that you have read and abide by the statements above. 1001032438
Hammond Manufacturing Company Ltd. Presented by Invest for Value
Net-Net stock with 0% margin of safety Invest for Value team did a good job in finding a stock which is close to be called as Net-Net i.e. Market Capitalization of the stock is less than Total Current Assets Total Liabilities. Refer appendix 1 to understand why I say close to Net-Net. My objection with this investment is that there has to be sufficient margin of safety especially when you are investing in a nanocap. Ben Graham himself suggested that invest in the net-net stocks only when the stock is trading at 2/3rd or less of the net margin i.e. Market Cap <= 2/3 * (Total Current Assets Total Liabilities) so that there is sufficient margin of safety. If things doesnt pan out the way you are expecting, then you have downside protection. Also, the whole premise behind buying net-net stock is that you will get profited if the firm liquidates. If the firm does not liquidate then as an investor you will never realize the profits. Given that Hammond Manufacturing is in business since last 97 years and CEO owns 37.8% of the firm, there is a minuscule probability that he will allow the firm to be liquidated. Increasing EBITDA margin YoY is stretch Group has used increase in EBITDA margins of 30 bps YoY for next 10 years in forecasting FCFF which is a stretch. A firm can push margins consistently only if it has got strong moat or is a major player in that sector. I dont think either of the two things is true in case of Hammond. Refer appendix 2. Absence of a true catalyst Group didnt have a slide for a possible catalyst that can move the stock. Investing in nano-cap stocks should have a certain catalyst restructuring or involvement of activist investor or possibility of firm sell-off. Market can stay irrational for longer than you can stay liquid. Earnings growth assumption cant be a true catalyst in a thinly traded nano-cap stock because a. forecasting of earnings growth is extremely difficult b. earnings can be extremely volatile (Refer appendix 3). In case of Hammond, earnings has been extremely volatile in last 10 years. Strong Balance Sheet is Questionable Total current assets of the firm mainly constitute of accounts receivables and inventory (95%). Though, I remember group mentioned that they had word with the CEO and he assured about the quality of inventory and receivables, as an investor I wouldnt take managements analysis word for word. Cash position of the firm ($0.8M) stands at measly 1.9% of the total assets while short term borrowings ($9.8M) stand at 40% of total liabilities thus questioning the firms strong balance sheet position. Valuation of nano-cap firms should be balance sheet based and not income statement based I found the valuation done by the group to be bit unreasonable. Valuation of a nano-cap based on 10 year forecast would be highly unpredictable. Consistent increase in revenue and EBITDA margins for 10 years is definitely a stretch. If I were an investor, I would pay for the firm purely based on the balance sheet numbers. Assuming quality of inventory and receivables to be good, I would invest if Hammond were trading below 70% * (Total Current Assets Total Liabilities) i.e. 0.7*(40.6-22.7) = $12.5 million or 77 cents per share. Hence, I would liquidate my position in Hammond at the current stock price of $1.93.
APPENDIX 1: NET-NET STOCK
APPENDIX 2: INCOME STATEMENT PROJECTION
APPENDIX 3: HISTORICAL EARNINGS OF HAMMOND MANUFACTURING